The TRIUMPH Trial Program Eli Lilly's Phase 3 program includes eight trials spanning multiple conditions
Some members see changes in the first few weeks, while others notice progress over several months
For most people they reduce significantly after the initial adjustment period, though some residual nausea can persist at higher doses
For guidance on evaluating research peptide quality standards, see our how to choose a research peptide supplier guide and our comparison of best peptide companies in 2026
Because this is strictly an introductory dose rather than a therapeutic one, you may only experience mild appetite changes during the first few weeks
GLP-1, or glucagon-like peptide-1, is a powerful hormone that plays a crucial role in regulating blood sugar, enhancing insulin secretion, and promoting feelings of fullness